In addition, ANKDD1A also decreased the half-life of HIF1α by upregulating FIH1, decreased glucose uptake and lactate production, inhibited glioma cell autophagy, and induced apoptosis in GBM cells under hypoxia. Here, ANKDD1A is linked to central nervous system cancer.